NASDAQ:GLSI | Profit Breakdown | Greenwich LifeSciences, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$4.02M-$3.95M
2026-03-31-$5.73M-$5.66M
2025-12-31-$7.94M-$9.15M
2025-09-30-$4.17M-$4.15M
2025-06-30-$3.77M-$3.75M
2025-03-31-$2.77M-$2.74M
2024-12-31-$9.71M-$9.67M
2024-09-30-$2.73M-$2.67M
2024-06-30-$2.66M-$2.61M
2024-03-31-$2.54M-$2.47M
2023-12-31-$2.84M-$2.75M
2023-09-30-$2.5M-$2.39M
2023-06-30-$1.75M-$1.63M
2023-03-31-$2.24M-$2.12M
2022-12-31-$2.89M-$2.79M
2022-09-30-$2.38M-$2.32M
2022-06-30-$773,307.00-$746,073.00
2022-03-31-$1.99M-$1.97M
2021-12-31-$2.38M-$2.36M
2021-09-30-$866,686.00-$863,118.00
2021-06-30-$753,445.00-$749,745.00
2021-03-31-$600,606.00-$597,008.00
2020-12-31-$1.15M-$1.15M
2020-09-30-$256,865.00-$256,865.00
2020-06-30-$210,430.00-$210,430.00
2020-03-31-$244,641.00-$244,641.00
2019-12-31-$336,536.00-$336,536.00
2019-09-30-$336,013.00-$336,013.00
2019-06-30-$2.6M
2019-03-31-$148,731.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$19.45M-$19.36M
2024-12-31-$17.64M-$17.41M
2023-12-31-$9.33M-$8.89M
2022-12-31-$8.04M-$7.83M
2021-12-31-$4.6M-$4.57M
2020-12-31-$1.86M-$1.86M
2019-12-31-$3.43M-$3.43M